AAAAAA

   
Results: 1-24 |
Results: 24
Growth hormone receptor interaction with Jak proteins differs between tissues
Authors: Hellgren, G Albertsson-Wikland, K Billig, H Carlsson, LMS Carlsson, B
Citation: G. Hellgren et al., Growth hormone receptor interaction with Jak proteins differs between tissues, J INTERF CY, 21(2), 2001, pp. 75-83
The decrease of IGF-I, IGF-binding protein-3 and bone alkaline phosphataseisoforms during gluten challenge correlates with small intestinal inflammation in children with coeliac disease
Authors: Jansson, UHG Kristiansson, B Magnusson, P Larsson, L Albertsson-Wikland, K Bjarnason, R
Citation: Uhg. Jansson et al., The decrease of IGF-I, IGF-binding protein-3 and bone alkaline phosphataseisoforms during gluten challenge correlates with small intestinal inflammation in children with coeliac disease, EUR J ENDOC, 144(4), 2001, pp. 417-423
The potential of prediction models based on data from KIGS as tools to measure responsiveness to growth hormone
Authors: Ranke, MB Lindberg, A Chatelain, P Wilton, P Price, DA Albertsson-Wikland, K
Citation: Mb. Ranke et al., The potential of prediction models based on data from KIGS as tools to measure responsiveness to growth hormone, HORMONE RES, 55, 2001, pp. 44-48
Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents
Authors: Fors, H Bjarnason, R Wiren, L Albertsson-Wikland, K Bosaeus, I Bengtsson, BA Johansson, G
Citation: H. Fors et al., Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents, CLIN ENDOCR, 55(5), 2001, pp. 617-624
Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells:Direct correlation with clinical retinopathy of prematurity
Authors: Hellstrom, A Perruzzi, C Ju, MH Engstrom, E Hard, AL Liu, JL Albertsson-Wikland, K Carlsson, B Niklasson, A Sjodell, L LeRoith, D Senger, DR Smith, LEH
Citation: A. Hellstrom et al., Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells:Direct correlation with clinical retinopathy of prematurity, P NAS US, 98(10), 2001, pp. 5804-5808
Genetic analysis of mosaicism in 53 women with Turner syndrome
Authors: Hanson, L Bryman, I Barrenas, ML Janson, PO Wahlstrom, J Albertsson-Wikland, K Hanson, C
Citation: L. Hanson et al., Genetic analysis of mosaicism in 53 women with Turner syndrome, HEREDITAS, 134(2), 2001, pp. 153-159
Population-based body mass index reference values from Goteborg, Sweden: birth to 18 years of age
Authors: He, Q Albertsson-Wikland, K Karlberg, J
Citation: Q. He et al., Population-based body mass index reference values from Goteborg, Sweden: birth to 18 years of age, ACT PAEDIAT, 89(5), 2000, pp. 582-592
Serum leptin in short children born small for gestational age: Dose-dependent effect of growth hormone treatment
Authors: Boguszewski, MCS de Zegher, F Albertsson-Wikland, K
Citation: Mcs. Boguszewski et al., Serum leptin in short children born small for gestational age: Dose-dependent effect of growth hormone treatment, HORMONE RES, 54(3), 2000, pp. 120-125
Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment
Authors: Cutfield, WS Wilton, P Bennmarker, H Albertsson-Wikland, K Chatelain, P Ranke, MB Price, DA
Citation: Ws. Cutfield et al., Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment, LANCET, 355(9204), 2000, pp. 610-613
Long-term consequences of early linear growth retardation (stunting) in Swedish children
Authors: Liu, YX Albertsson-Wikland, K Karlberg, J
Citation: Yx. Liu et al., Long-term consequences of early linear growth retardation (stunting) in Swedish children, PEDIAT RES, 47(4), 2000, pp. 475-480
Growth hormone treatment of short children born small for gestational age:Growth responses with continuous and discontinuous regimens over 6 years
Authors: de Zegher, F Albertsson-Wikland, K Wollmann, HA Chatelain, P Chaussain, JL Lofstrom, A Jonsson, B Rosenfeld, RG
Citation: F. De Zegher et al., Growth hormone treatment of short children born small for gestational age:Growth responses with continuous and discontinuous regimens over 6 years, J CLIN END, 85(8), 2000, pp. 2816-2821
Prediction of long-term response to recombinant human growth hormone in Turner syndrome: Development and validation of mathematical models
Authors: Ranke, MB Lindberg, A Chatelain, P Wilton, P Cutfield, W Albertsson-Wikland, K Price, DA
Citation: Mb. Ranke et al., Prediction of long-term response to recombinant human growth hormone in Turner syndrome: Development and validation of mathematical models, J CLIN END, 85(11), 2000, pp. 4212-4218
Changes in body composition and leptin levels during growth hormone (GH) treatment in short children with various GH secretory capacities (vol 140, pg 35, 1999)
Authors: Matsuoka, H Fors, H Bosaeus, I Rosberg, S Albertsson-Wikland, K Bjarnason, R
Citation: H. Matsuoka et al., Changes in body composition and leptin levels during growth hormone (GH) treatment in short children with various GH secretory capacities (vol 140, pg 35, 1999), EUR J ENDOC, 140(3), 1999, pp. 268-268
Changes in body composition and leptin levels during growth hormone (GH) treatment in short children with various GH secretory capacities
Authors: Matsuoka, H Fors, H Bosaeus, I Rosberg, S Albertsson-Wikland, K Bjarnason, R
Citation: H. Matsuoka et al., Changes in body composition and leptin levels during growth hormone (GH) treatment in short children with various GH secretory capacities, EUR J ENDOC, 140(1), 1999, pp. 35-42
Prevalence of coeliac disease in Turner syndrome
Authors: Ivarsson, SA Carlsson, A Bredberg, A Alm, J Aronsson, S Gustafsson, J Hagenas, L Hager, A Kristrom, B Marcus, C Moell, C Nilsson, KO Tuvemo, T Westphal, O Albertsson-Wikland, K Aman, J
Citation: Sa. Ivarsson et al., Prevalence of coeliac disease in Turner syndrome, ACT PAEDIAT, 88(9), 1999, pp. 933-936
Predicting the response to recombinant human growth hormone in Turner syndrome: KIGS models
Authors: Ranke, MB Lindberg, A Chatelain, P Wilton, P Cutfield, W Albertsson-Wikland, K Price, DA
Citation: Mb. Ranke et al., Predicting the response to recombinant human growth hormone in Turner syndrome: KIGS models, ACT PAEDIAT, 88, 1999, pp. 122-125
Should we treat children with idiopathic short stature? Workshop held in St.-Paul-de-Vence, France, April 18-19, 1999
Authors: Kelnar, CJH Albertsson-Wikland, K Hintz, RL Ranke, MB Rosenfeld, RG
Citation: Cjh. Kelnar et al., Should we treat children with idiopathic short stature? Workshop held in St.-Paul-de-Vence, France, April 18-19, 1999, HORMONE RES, 52(3), 1999, pp. 150-157
Monthly measurements of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in healthy prepubertal children: Characterization and relationship with growth: The 1-year growth study
Authors: Gelander, L Blum, WF Larsson, L Rosberg, S Albertsson-Wikland, K
Citation: L. Gelander et al., Monthly measurements of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in healthy prepubertal children: Characterization and relationship with growth: The 1-year growth study, PEDIAT RES, 45(3), 1999, pp. 377-383
Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency
Authors: Ranke, MB Lindberg, A Chatelain, P Wilton, P Cutfield, W Albertsson-Wikland, K Price, DA
Citation: Mb. Ranke et al., Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency, J CLIN END, 84(4), 1999, pp. 1174-1183
Reduced retinal vascularization in children with growth hormone deficiency
Authors: Hellstrom, A Svensson, E Carlsson, B Niklasson, A Albertsson-Wikland, K
Citation: A. Hellstrom et al., Reduced retinal vascularization in children with growth hormone deficiency, J CLIN END, 84(2), 1999, pp. 795-798
Discontinuation of growth hormone (GH) treatment: Metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects
Authors: Johannsson, G Albertsson-Wikland, K Bengtsson, BA
Citation: G. Johannsson et al., Discontinuation of growth hormone (GH) treatment: Metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects, J CLIN END, 84(12), 1999, pp. 4516-4524
Optic nerve hypoplasia with isolated tortuosity of the retinal veins - A marker of endocrinopathy
Authors: Hellstrom, A Wiklund, LM Svensson, E Albertsson-Wikland, K Stromland, K
Citation: A. Hellstrom et al., Optic nerve hypoplasia with isolated tortuosity of the retinal veins - A marker of endocrinopathy, ARCH OPHTH, 117(7), 1999, pp. 880-884
Variations in glucocorticoid levels within the physiological range affect plasma leptin levels
Authors: Elimam, A Knutsson, U Bronnegard, M Stierna, P Albertsson-Wikland, K Marcus, C
Citation: A. Elimam et al., Variations in glucocorticoid levels within the physiological range affect plasma leptin levels, EUR J ENDOC, 139(6), 1998, pp. 615-620
Length and body mass index at birth and target height influences on patterns of postnatal growth in children born small for gestational age
Authors: Luo, ZC Albertsson-Wikland, K Karlberg, J
Citation: Zc. Luo et al., Length and body mass index at birth and target height influences on patterns of postnatal growth in children born small for gestational age, PEDIATRICS, 102(6), 1998, pp. E721-E727
Risultati: 1-24 |